학술논문
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1–Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial
Document Type
Article
Author
Reck, Martin; Barlesi, Fabrice; Yang, James Chih-Hsin; Westeel, Virginie; Felip, Enriqueta; Özgüroğlu, Mustafa; Dols, Manuel Cobo; Sullivan, Richard; Kowalski, Dariusz M.; Andric, Zoran; Lee, Dae Ho; Sezer, Ahmet; Hu, Ping; Wang, XiaoZhe; von Heydebreck, Anja; Jacob, Natalia; Mehr, Keyvan Tadjalli; Park, Keunchil
Source
In Journal of Thoracic Oncology February 2024 19(2):297-313
Subject
Language
ISSN
1556-0864